Sudarshan Pharma Industries
BSE 543828
3 stories, newest first.
- Shares admitted to dealings on NSE Main Board from October 27, 2026 after migration from BSE SME
- Acquisition proposal for 9.50% of Med Therapy Biotechnology Inc., USA stands terminated
- Completes Sale of 51% Stake in Ishwari Healthcare; Unit Ceases to Be a Subsidiary
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.